CD34+CD38+CD19+ as well as CD34+CD38-CD19+ cells are leukemia-initiating cells with self-renewal capacity in human B-precursor ALL

被引：128

作者：

Kong, Y. ^{[2
,3
]}

Yoshida, S. ^{[2
]}

Saito, Y.

Doi, T.

Nagatoshi, Y. ^{[4
]}

Fukata, M. ^{[2
]}

Saito, N. ^{[2
]}

Yang, S. M. ^{[3
]}

Iwamoto, C. ^{[2
]}

Okamura, J. ^{[4
]}

Liu, K. Y. ^{[3
]}

Huang, X. J. ^{[3
]}

Lu, D. P. ^{[3
]}

Shultz, L. D. ^{[5
]}

Harada, M.

Ishikawa, F. ^{[1
]}

机构：

[1] RIKEN RCAI, Res Unit Human Dis Models, Tsurumi Ku, Kanagawa 2300045, Japan

[2] Kyushu Univ, Grad Sch Med Sci, Dept Med & Biosyst Sci, Fukuoka 812, Japan

[3] Peking Univ, Peoples Hosp, Inst Hematol, Beijing 100871, Peoples R China

[4] Kyushu Natl Canc Ctr, Dept Pediat, Fukuoka, Japan

[5] Jackson Lab, Bar Harbor, ME 04609 USA

来源：

LEUKEMIA | 2008年 / 22卷 / 06期

基金：

美国国家卫生研究院;

关键词：

acute lymphocytic leukemia; stem cells; transplantation;

D O I：

10.1038/leu.2008.83

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

The presence of rare malignant stem cells supplying a hierarchy of malignant cells has recently been reported. In human acute myelogenous leukemia (AML), the leukemia stem cells (LSCs) have been phenotypically restricted within the CD34+CD38- fraction. To understand the origin of malignant cells in primary human B-precursor acute lymphocytic leukemia (B-ALL), we established a novel in vivo xenotransplantation model. Purified CD34+CD38+CD19+, CD34+CD38-CD19+ and CD34+CD38-CD19- bone marrow ( BM) or peripheral blood (PB) cells from three pediatric B-ALL patients were intravenously injected into sublethally irradiated newborn NOD/SCID/IL2r gamma(null) mice. We found that both CD34+CD38+CD19+ and CD34+CD38-CD19+ cells initiate B-ALL in primary recipients, whereas the recipients of CD34+CD38-CD10-CD19- cells showed normal human hematopoietic repopulation. The extent of leukemic infiltration into the spleen, liver and kidney was similar between the recipients transplanted with CD34+CD38+CD19+ cells and those transplanted with CD34+CD38-CD19+ cells. In each of the three cases studied, transplantation of CD34+CD38+CD19+ cells resulted in the development of B-ALL in secondary recipients, demonstrating self-renewal capacity. The identification of CD34+CD38+ CD19+ self-renewing B-ALL cells proposes a hierarchy of leukemia-initiating cells (LICs) distinct from that of AML. Recapitulation of patient B-ALL in NOD/SCID/IL2r gamma(null) recipients provides a powerful tool for directly studying leukemogenesis and for developing therapeutic strategies.

引用

页码：1207 / 1213

页数：7

共 50 条

[41] Cell-surface Notch1 expression identifies a primitive phenotype within CD34+CD38- haematopoietic cells [J].

Portillo, Virginia ;

Chadwick, Nicholas ;

Lloyd, Ruth ;

Jackson, Dean ;

Buckle, Anne-Marie .

EUROPEAN JOURNAL OF HAEMATOLOGY, 2014, 92 (01) :26-34

[42] Comparative characterization of CD271+ and CD271- subpopulations of CD34+ human adipose-derived stromal cells [J].

Beckenkamp, Liziane R. ;

Souza, Lucas E. B. ;

Melo, Fernanda U. F. ;

Thome, Carolina H. ;

Magalhaes, Daniele A. R. ;

Palma, Patricia V. B. ;

Covas, Dimas T. .

JOURNAL OF CELLULAR BIOCHEMISTRY, 2018, 119 (05) :3873-3884

[43] T-, B- and NK-lymphoid, but not myeloid cells arise from human CD34+CD38−CD7+ common lymphoid progenitors expressing lymphoid-specific genes [J].

I Hoebeke ;

M De Smedt ;

F Stolz ;

K Pike-Overzet ;

F J T Staal ;

J Plum ;

G Leclercq .

Leukemia, 2007, 21 :311-319

[44] Human bone marrow CD34- cells engraft in vivo and undergo multilineage expression that includes giving rise to CD34+ cells [J].

Zanjani, ED ;

Almeida-Porada, G ;

Livingston, AG ;

Flake, AW ;

Ogawa, M .

EXPERIMENTAL HEMATOLOGY, 1998, 26 (04) :353-360

[45] Differential response of primitive human CD34− and CD34+ hematopoietic cells to the Notch ligand Jagged-1 [J].

F N Karanu ;

L Yuefei ;

L Gallacher ;

S Sakano ;

M Bhatia .

Leukemia, 2003, 17 :1366-1374

[46] Differential response of primitive human CD34- and CD34+ hematopoietic cells to the Notch ligand Jagged-1 [J].

Karanu, FN ;

Yuefei, L ;

Gallacher, L ;

Sakano, S ;

Bhatia, M .

LEUKEMIA, 2003, 17 (07) :1366-1374

[47] CD133+CD34+ cells can give rise to EPCs: A comparative rabbit and human study [J].

Chopra, Hitesh ;

Han, Yuanyuan ;

Zhang, Chengfei ;

Pow, Edmond Ho Nang .

BLOOD CELLS MOLECULES AND DISEASES, 2021, 86

[48] Marked elevation of circulating CD19+CD38hiCD24hi transitional B cells give protection against neonatal sepsis [J].

Li, Sitao ;

Ma, Fei ;

Hao, Hu ;

Wang, Desheng ;

Gao, Yu ;

Zhou, Jialiang ;

Li, Fei ;

Lin, Hung-Chih ;

Xiao, Xin ;

Zeng, Qiyi .

PEDIATRICS AND NEONATOLOGY, 2018, 59 (03) :296-304

[49] Dual SP/ALDH Functionalities Refine the Human Hematopoietic Lin-CD34+CD38- Stem/Progenitor Cell Compartment [J].

Pierre-Louis, Olivier ;

Clay, Denis ;

de la Grange, Philippe Brunet ;

Blazsek, Istvan ;

Desterke, Christophe ;

Guerton, Bernadette ;

Blondeau, Camille ;

Malfuson, Jean-Valere ;

Prat, Marie ;

Bennaceur-Griscelli, Annelise ;

Lataillade, Jean-Jacques ;

Le Bousse-Kerdiles, Marie-Caroline .

STEM CELLS, 2009, 27 (10) :2552-2562

[50] High ALDHdim-expressing CD34+CD38- cells in leukapheresed peripheral blood is a reliable guide for a successful leukemic xenograft model of acute myeloid leukemia [J].

Lee, Ji Yoon ;

Park, Sohye ;

Han, A-Reum ;

Lim, Jihyang ;

Min, Woo-Sung ;

Kim, Hee-Je .

ONCOLOGY REPORTS, 2014, 32 (04) :1638-1646

← 1 2 3 4 5 →